# OnCo record mcgill-goodman (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/mcgill-goodman/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "mcgill-goodman" ;
  schema:name "Rosalind and Morris Goodman Cancer Institute, McGill University"@en ;
  schema:alternateName "Goodman Cancer Institute"@en, "McGill Cancer Centre"@en ;
  schema:description "McGill's Goodman Cancer Institute builds on the 1965 discovery here of carcinoembryonic antigen, the first clinically used tumour marker; its groups study breast cancer metastasis, mRNA translation control and tumour metabolism, and William Muller's HER2 mouse models are used worldwide."@en ;
  schema:url <https://onco.cc/institutions/mcgill-goodman/>, <https://www.mcgill.ca/gci/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.mcgill.ca/gci/>, <https://www.mcgill.ca> ;
  schema:addressCountry "CA" ;
  schema:addressLocality "Montréal, QC" ;
  schema:latitude "45.504"^^xsd:decimal ;
  schema:longitude "-73.577"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/metabolic-therapy/>, <https://onco.cc/technologies/pdx-models/> ;
  onco:targets <https://onco.cc/targets/ceacam5/>, <https://onco.cc/targets/her2/> ;
  onco:people <https://onco.cc/people/john-stagg/>, <https://onco.cc/people/jonathan-spicer/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-metastasis-biology/>, <https://onco.cc/bottlenecks/b-preclinical-models/> .
